How far till Longevity Escape Velocity?

They say aging is just a part of life, but have you ever wondered if it really has to be? What if getting older isn’t just something we accept but something we could actually treat? 

 

In this riveting episode of Peak Human Labs Podcast,  Dr. Sanjeev Goel, sits down with Dr. Aubrey de Grey, a trailblazing biomedical gerontologist and Chief Science Officer of the SENS Research Foundation. They dive deep into the revolutionary idea of treating aging as a medical condition. They explore how damage accumulates in our bodies over time and discuss the groundbreaking medical advancements that could extend our healthy lifespans. Dr. de Grey sheds light on the crucial need for investing in underfunded research and shares insights into the future of longevity science. Tune in and envision a future where health and longevity are not just aspirations but achievable realities!

 

Click HERE to sign in for Dublin Longevity Declaration.

Key Takeaways

• Aging as a medical condition versus a natural process
• Mechanisms of damage accumulation in the body
• Concept of "longevity escape velocity"
• Role of epigenetic changes in aging
• Importance of comprehensive interventions targeting different types of damage
• Current state of therapies for extending human lifespan
• Economic implications of aging therapies and preventative medicine
• Research on retroviruses and chronic infections in relation to aging
• Innovative therapies such as hyperbaric oxygen therapy and therapeutic blood exchange
• The significance of personalized health approaches and the microbiome's impact on longevity

 

In This Episode:

• [00:00:00] Introduction to longevity research
• [00:00:51] Guest introduction
• [00:01:17] Personal connection
• [00:02:04] Dr. de Grey's background
• [00:03:14] Early research stages
• [00:04:05] Understanding aging as a machine
• [00:05:22] Accumulated damage mechanism
• [00:06:15] Comprehensive medical control
• [00:07:13] Categories of damage
• [00:07:55] Wear and tear concept
• [00:09:20] Epigenetic changes discussion
• [00:11:31] Partial reprogramming concept
• [00:13:30] Addressing multiple mechanisms
• [00:14:31] Longevity escape velocity
• [00:15:43] Initial pushback on longevity ideas
• [00:17:51] Positive outlook on aging research
• [00:19:51] The future of longevity research
• [00:20:54] Funding disparities in research
• [00:21:10] Business models in longevity research
• [00:21:58] Combining existing therapies
• [00:23:47] Current longevity therapies
• [00:24:56] Caloric restriction vs. drugs
• [00:25:36] Dublin Longevity Declaration
• [00:28:09] Anticipating longevity breakthroughs
• [00:29:12] Access to longevity therapies
• [00:30: